atezolizumab,talazoparib
roche,pfizer
['talazo', 'biomarker', 'lung', 'sclc', 'lcsm,(-blcsm)']
dr. presents results of s1929 at #asco23:
adding a parp inhibitor (talazoparib) to checkpoint blockade significantly extended pfs for patients w extensive-stage small-cell #lungcancer whose tumors express slfn11. biomarker selected treatment in #sclc #lcsm 
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.